ECIR

Name

ECIR

Legal name

Decera Clinical

Website

https://ecirmedcom.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Medical Communications and Healthcare Professional Education

NAICS

Educational Support Services (61171), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industry

Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC)

Keywords

• Medical communications services
• Accredited medical education
• HCP insights research
• Pharmaceutical education programs
• Clinical evidence translation

Headquarters

HQ city

Jacksonville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Accredited Education Services: Accredited CME/CE education programs that translate clinical evidence into better clinical decisions. The company develops and delivers educational content for healthcare professionals across 20+ specialties, helping them stay current with evidence and improve patient outcomes.
2. HCP Insights Research: Custom research and intelligence services that uncover HCP behavior, barriers, beliefs, motivations, and unmet needs in therapeutic areas. Delivered as decision-ready insights for pharmaceutical and biotech asset strategy teams.
3. Strategic Medical Communications: Medical communications services including publications, expert panels, and strategic communications that turn complex data into compelling narratives across the asset lifecycle.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

ECIR (Decera Clinical) delivers accredited CME/CE education, HCP (healthcare professional) insights research, and strategic medical communications services to pharmaceutical and biotechnology companies across the full product lifecycle. The company operates a proprietary Scientific Activation™ methodology built on the DECODE framework (Detect the Signal, Connect to the Context, Design to Activate) to translate clinical evidence into clinical action by healthcare professionals across 20+ therapeutic specialties.

Product overview

Decera Clinical operates as a Scientific Activation platform offering three integrated solutions—Education Solutions, Insights Solutions, and Communications Solutions—supported by the proprietary DECODE methodology. Education delivers accredited CME/CE programs across 20+ specialties; Insights provides HCP intelligence for asset strategy; and Communications creates strategic medical narratives across the product lifecycle. The company serves healthcare professionals and life sciences companies (biotech and pharma) with a reported network of 1.4M+ HCPs and partnerships with 100% of Top 20 pharma companies.

Differentiator

Problem solved

Functional benefit

Brands

• Scientific Activation: Proprietary methodology/process branded as 'Scientific Activation' that enables moving healthcare professionals from evidence to action through the DECODE process (Detect, Connect, Design, Activate).

Products and services

• Education Solutions Accredited CME/CE education programs that translate clinical evidence into better decisions at the bedside, covering 20+ medical specialties and aimed at sharpening judgment, building confidence, and improving patient outcomes for healthcare professionals.
• Insights Solutions HCP intelligence services that uncover the real-world context behind healthcare professional behavior — including barriers, beliefs, motivations, and unmet needs shaping a therapeutic area — delivered decision-ready to pharmaceutical and biotech asset strategy teams.
• Communications Solutions Strategic medical communications that turn complex clinical data into compelling narratives ready to deploy across the full product lifecycle, powered by deep scientific expertise and proprietary insights to help clients drive understanding and adoption at scale.

Quantifiable outcome

• 2.5M+ patient care decisions improved every week
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Partners for Advancing Clinical EducationcoreStrategic or Co-development PartnerA subsidiary or closely aligned partner organization focused on advancing clinical education standards. Listed in Decera Clinical's solution ecosystem alongside their core Education, Insights, and Communications offerings.
• liV AgencycoreStrategic or Co-development PartnerA creative/strategic agency partner (livagency.ca) integrated into Decera Clinical's partner ecosystem. Supports the company's mission to deliver scientific activation and medical communications services.

Scale indicators7 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• MedThink Communications: MedThink Communications provides medical communications, medical affairs, and healthcare marketing services to pharma and biotech clients. Directly comparable peer serving the same enterprise customer base with overlapping solutions.
• ProEd Communications: ProEd Communications is a continuing medical education provider offering accredited CME/CE programming for HCPs across therapeutic areas. Directly comparable in scale and service mix to Decera's Education Solutions line.
• International Medical Press: International Medical Press produces accredited CME/CE programs and peer-reviewed medical content distributed to HCPs across therapeutic areas, frequently in partnership with pharma sponsors. Comparable peer in both education and medical publishing.
• Clinical Care Options: Clinical Care Options is a direct peer that develops accredited CME/CE programs and clinical decision-support tools for HCPs across multiple specialties, partnering with pharma to deliver medical education. Closely mirrors Decera's Education Solutions and adjacent insights offerings.
• touchIME (Touch Medical): touchIME delivers free, independent accredited CME education and medical communications to specialists globally, often in partnership with life sciences companies. Comparable peer in CME delivery and HCP-focused scientific content.
• PVI (PeerVoice): PeerVoice produces accredited CME/CE activities in collaboration with expert faculty and pharma sponsors, focused on engaging HCPs through short-form, high-impact educational formats. Directly comparable peer in pharma-sponsored HCP education.

Broad incumbents

• IQVIA Medical Communications: IQVIA operates one of the largest medical communications and clinical education businesses globally as part of its broader life sciences services portfolio. Overlaps with Decera across communications, HCP engagement, and education, but at vastly greater scale and as part of a broader CRO/commercial stack.
• Medscape (WebMD Health): Medscape is the largest free, accredited CME/CE destination for HCPs globally and a scaled incumbent in pharma-funded medical education and communications. Competes with Decera for HCP reach and pharma-sponsored education budgets, with much larger audience and infrastructure.
• Syneos Health Communications: Syneos Health Communications offers strategic medical communications, publications, and HCP engagement services within its larger contract commercialization and CRO portfolio. Competes for the same pharma medical affairs and medcomms budgets as Decera, with broader delivery capabilities.
• Publicis Health / CMGRP: Publicis Health operates multiple large medical communications and healthcare advertising agencies (including legacy CMI/CMGRP) serving Top 20 pharma with end-to-end medcomms capabilities. Represents the scaled incumbent alternative that Decera competes against for enterprise medcomm mandates.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ECIRMedCom

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ECIR